Seasoned Directors further strengthen Board with decades of industry and leadership experienceAUSTIN, Texas, June 23, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the appointments of two seasoned Board members: Dr. Robert Auerbach and Ms. Ruby Sharma. Dr. Auerbach retired President of CooperSurgical Inc., brings extensive experience in the medical industry, including experience as a d
Paper published in the June online issue of JCO Clinical Cancer InformaticsAUSTIN, Texas, June 16, 2022 (GLOBE NEWSWIRE) -- Aspira Women’s Health Inc. (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the online publication of a paper validating its OvaWatch™ algorithm in the detection of ovarian cancer in the June issue of JCO Clinical Cancer Informatics. The paper, entitled: “Analytical Validation of a Deep Neural Network Algorithm for th
Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...